Clinical presentation of patients
No. . | Sex . | Age, y . | FAB . | Karyotype . | WBC count, × 109/L . | Blasts in PBLs, % . | LDH level, U/mL . |
|---|---|---|---|---|---|---|---|
| 1 | M | 58 | M4Eo | 47,XY,+8,inv(16)(p13q22) | 22.2 | 78 | 954 |
| 2 | M | 64 | M4Eo | 46,XY,inv(16)(p13q22) | 14.3 | 54 | 752 |
| 3 | F | 58 | M4Eo | 47,XX,inv(16)(p13q22),+22 | 13.2 | 58 | 674 |
| 4 | M | 46 | M4Eo | 46,XY,t(9;20;21),inv(16)(p13q22) | 38.4 | 95 | 1455 |
| 5 | F | 62 | M4Eo | 46,XX,inv(16)(p13q22) | 55.8 | 98 | 1025 |
| 6 | M | 54 | M4Eo | 46,XY,inv(16)(p13q22) | 18.2 | 45 | 770 |
| 7 | F | 62 | M4Eo | 46,XX,inv(16)(p13q22) | 8.2 | 25 | 482 |
| 8 | M | 49 | M4Eo | 47,XY,inv(16)(p13q22),+21 | 15.3 | 38 | 920 |
| 9 | F | 72 | M4Eo | 46,XX,inv(16)(p13q22) | 32.8 | 90 | 1285 |
| 10 | F | 48 | M4Eo | 46,XX,del(7q),inv(16)(p13q22) | 9.1 | 32 | 474 |
| 11 | M | 70 | M4Eo | 46,XY,inv(16)(p13q22) | 18.2 | 41 | 552 |
| 12 | M | 58 | M4Eo | 46,XY,inv(16)(p13q22) | 104.8 | 92 | 1485 |
| 13 | M | 44 | M4 | 46,XY | 6.6 | 30 | 380 |
| 14 | F | 61 | M4 | 46,XX | 22.8 | 68 | 884 |
| 15 | M | 58 | M4 | 46,XY | 14.4 | 55 | 710 |
| 16 | M | 58 | M4 | 46,XY | 98.8 | 98 | 1662 |
| 17 | F | 74 | M4 | 46,XX | 30.5 | 72 | 980 |
| 18 | M | 62 | M4 | 46,XY | 84.5 | 98 | 1585 |
No. . | Sex . | Age, y . | FAB . | Karyotype . | WBC count, × 109/L . | Blasts in PBLs, % . | LDH level, U/mL . |
|---|---|---|---|---|---|---|---|
| 1 | M | 58 | M4Eo | 47,XY,+8,inv(16)(p13q22) | 22.2 | 78 | 954 |
| 2 | M | 64 | M4Eo | 46,XY,inv(16)(p13q22) | 14.3 | 54 | 752 |
| 3 | F | 58 | M4Eo | 47,XX,inv(16)(p13q22),+22 | 13.2 | 58 | 674 |
| 4 | M | 46 | M4Eo | 46,XY,t(9;20;21),inv(16)(p13q22) | 38.4 | 95 | 1455 |
| 5 | F | 62 | M4Eo | 46,XX,inv(16)(p13q22) | 55.8 | 98 | 1025 |
| 6 | M | 54 | M4Eo | 46,XY,inv(16)(p13q22) | 18.2 | 45 | 770 |
| 7 | F | 62 | M4Eo | 46,XX,inv(16)(p13q22) | 8.2 | 25 | 482 |
| 8 | M | 49 | M4Eo | 47,XY,inv(16)(p13q22),+21 | 15.3 | 38 | 920 |
| 9 | F | 72 | M4Eo | 46,XX,inv(16)(p13q22) | 32.8 | 90 | 1285 |
| 10 | F | 48 | M4Eo | 46,XX,del(7q),inv(16)(p13q22) | 9.1 | 32 | 474 |
| 11 | M | 70 | M4Eo | 46,XY,inv(16)(p13q22) | 18.2 | 41 | 552 |
| 12 | M | 58 | M4Eo | 46,XY,inv(16)(p13q22) | 104.8 | 92 | 1485 |
| 13 | M | 44 | M4 | 46,XY | 6.6 | 30 | 380 |
| 14 | F | 61 | M4 | 46,XX | 22.8 | 68 | 884 |
| 15 | M | 58 | M4 | 46,XY | 14.4 | 55 | 710 |
| 16 | M | 58 | M4 | 46,XY | 98.8 | 98 | 1662 |
| 17 | F | 74 | M4 | 46,XX | 30.5 | 72 | 980 |
| 18 | M | 62 | M4 | 46,XY | 84.5 | 98 | 1585 |
FAB indicates French-American-British classification; WBC, white blood cell; PBLs, peripheral blood leukocytes; LDH, lactate dehydrogenase.